JPS4954390A - - Google Patents
Info
- Publication number
- JPS4954390A JPS4954390A JP48069691A JP6969173A JPS4954390A JP S4954390 A JPS4954390 A JP S4954390A JP 48069691 A JP48069691 A JP 48069691A JP 6969173 A JP6969173 A JP 6969173A JP S4954390 A JPS4954390 A JP S4954390A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2230154A DE2230154A1 (de) | 1972-06-21 | 1972-06-21 | N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS4954390A true JPS4954390A (ja) | 1974-05-27 |
JPS5614673B2 JPS5614673B2 (ja) | 1981-04-06 |
Family
ID=5848276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6969173A Expired JPS5614673B2 (ja) | 1972-06-21 | 1973-06-20 |
Country Status (14)
Country | Link |
---|---|
US (1) | US3931189A (ja) |
JP (1) | JPS5614673B2 (ja) |
AT (7) | AT328101B (ja) |
BE (1) | BE801271A (ja) |
CH (7) | CH585753A5 (ja) |
DE (1) | DE2230154A1 (ja) |
DK (1) | DK141629C (ja) |
ES (3) | ES416106A1 (ja) |
FI (1) | FI57261C (ja) |
FR (1) | FR2189066B1 (ja) |
GB (1) | GB1431385A (ja) |
NL (1) | NL7308555A (ja) |
NO (1) | NO139050C (ja) |
SE (1) | SE412235B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005506985A (ja) * | 2001-09-14 | 2005-03-10 | インスティチュート オブ ファーマコロジー アンド トクシコロジー アカデミー オブ ミリタリー メディカル サイエンス、 ピー.エル.エー.チャイナ | 新規オリパビン誘導体および医薬としてのその使用 |
WO2019189749A1 (ja) * | 2018-03-30 | 2019-10-03 | 日本ケミファ株式会社 | モルヒナン誘導体の製造方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4232026A (en) * | 1978-07-20 | 1980-11-04 | Merck & Co., Inc. | Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them |
JPS60119848A (ja) * | 1983-11-30 | 1985-06-27 | 三井建設株式会社 | 繊維補強コンクリ−ト並びにその施工法 |
JPS62298530A (ja) * | 1986-06-16 | 1987-12-25 | Otsuka Pharmaceut Co Ltd | 坐薬用医薬組成物 |
CN1939920B (zh) * | 2005-09-29 | 2011-08-31 | 中国人民解放军军事医学科学院毒物药物研究所 | 东罂粟碱类化合物及其医药用途 |
KR101343395B1 (ko) | 2008-07-30 | 2013-12-19 | 퍼듀 퍼머 엘피 | 부프레노르핀 유사체 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3474101A (en) * | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
US3285914A (en) * | 1964-06-11 | 1966-11-15 | Smith Kline French Lab | 3-n-substituted derivatives of oripavine and thebaine |
GB1136764A (en) * | 1965-08-13 | 1968-12-18 | Reckitt & Sons Ltd | Derivatives of thebaine and oripavine |
GB1146272A (en) * | 1966-01-17 | 1969-03-26 | Reckitt & Sons Ltd | Novel thebaine and oripavine derivatives |
GB1223445A (en) * | 1968-07-18 | 1971-02-24 | Reckitt & Colmann Prod Ltd | Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation |
DE2107989A1 (de) * | 1971-02-19 | 1972-09-07 | Boehringer Sohn Ingelheim | N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung |
-
1972
- 1972-06-21 DE DE2230154A patent/DE2230154A1/de not_active Withdrawn
-
1973
- 1973-06-06 AT AT462174*7A patent/AT328101B/de not_active IP Right Cessation
- 1973-06-06 AT AT462274*7A patent/AT327409B/de not_active IP Right Cessation
- 1973-06-06 AT AT494473A patent/AT325219B/de not_active IP Right Cessation
- 1973-06-06 AT AT462074*7A patent/AT328100B/de not_active IP Right Cessation
- 1973-06-06 AT AT461974*7A patent/AT328099B/de not_active IP Right Cessation
- 1973-06-06 AT AT462374*7A patent/AT329198B/de not_active IP Right Cessation
- 1973-06-06 AT AT461874*7A patent/AT328098B/de not_active IP Right Cessation
- 1973-06-13 US US05/369,500 patent/US3931189A/en not_active Expired - Lifetime
- 1973-06-18 CH CH1461076A patent/CH585753A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH1460976A patent/CH585752A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH1460676A patent/CH587264A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH1460776A patent/CH586224A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH881573A patent/CH585751A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH1461176A patent/CH594673A5/xx not_active IP Right Cessation
- 1973-06-18 CH CH1460876A patent/CH594672A5/xx not_active IP Right Cessation
- 1973-06-20 JP JP6969173A patent/JPS5614673B2/ja not_active Expired
- 1973-06-20 ES ES416106A patent/ES416106A1/es not_active Expired
- 1973-06-20 NO NO2561/73A patent/NO139050C/no unknown
- 1973-06-20 DK DK341273A patent/DK141629C/da active
- 1973-06-20 NL NL7308555A patent/NL7308555A/xx not_active Application Discontinuation
- 1973-06-20 SE SE7308709A patent/SE412235B/xx unknown
- 1973-06-20 FI FI1989/73A patent/FI57261C/fi active
- 1973-06-20 GB GB2934673A patent/GB1431385A/en not_active Expired
- 1973-06-21 BE BE132576A patent/BE801271A/xx unknown
- 1973-06-21 FR FR7322738A patent/FR2189066B1/fr not_active Expired
-
1974
- 1974-04-05 ES ES425015A patent/ES425015A1/es not_active Expired
- 1974-04-05 ES ES425010A patent/ES425010A1/es not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005506985A (ja) * | 2001-09-14 | 2005-03-10 | インスティチュート オブ ファーマコロジー アンド トクシコロジー アカデミー オブ ミリタリー メディカル サイエンス、 ピー.エル.エー.チャイナ | 新規オリパビン誘導体および医薬としてのその使用 |
WO2019189749A1 (ja) * | 2018-03-30 | 2019-10-03 | 日本ケミファ株式会社 | モルヒナン誘導体の製造方法 |